Trials / Completed
CompletedNCT04273321
Efficacy and Safety of Corticosteroids in COVID-19
Efficacy and Safety of Corticosteroids in COVID-19: A Prospective Randomized Controlled Trails
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 86 (actual)
- Sponsor
- Beijing Chao Yang Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
There is still controversy about the effective of glucocorticoids for the treatment of novel coronavirus pneumonia. This is a prospective randomized controlled trails. The aim is to explore the effectiveness and safety of glucocorticoids in the treatment of novel coronavirus pneumonia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Methylprednisolone | Methylprednisolone 1mg/kg/day ivgtt for 7 days. |
Timeline
- Start date
- 2020-02-14
- Primary completion
- 2020-04-15
- Completion
- 2020-04-15
- First posted
- 2020-02-18
- Last updated
- 2020-05-11
Locations
7 sites across 1 country: China
Source: ClinicalTrials.gov record NCT04273321. Inclusion in this directory is not an endorsement.